Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARRIVE Study
2006-003622-29Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cardiac morbidity comparing Aspirin with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Apr 2007; status: completed.
02
Drugs
aspirin
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2006-003622-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003622-29.